AKPENTOLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Akpentolate, and what generic alternatives are available?
Akpentolate is a drug marketed by Rising and is included in two NDAs.
The generic ingredient in AKPENTOLATE is cyclopentolate hydrochloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AKPENTOLATE?
- What are the global sales for AKPENTOLATE?
- What is Average Wholesale Price for AKPENTOLATE?
Summary for AKPENTOLATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Patent Applications: | 1,395 |
| DailyMed Link: | AKPENTOLATE at DailyMed |
US Patents and Regulatory Information for AKPENTOLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | AKPENTOLATE | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 040164-001 | Jan 13, 1997 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Rising | AKPENTOLATE | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 040165-001 | Jan 13, 1997 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
